United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$266.05 USD
+4.96 (1.90%)
Updated May 9, 2024 04:00 PM ET
After-Market: $265.84 -0.21 (-0.08%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $6.13 | 1.09% |
Earnings Summary
For their last quarter, United Therapeutics (UTHR) reported earnings of $6.17 per share, beating the Zacks Consensus Estimate of $5.63 per share. This reflects a positive earnings surprise of 9.59%. Look out for UTHR's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of $6.13 per share, reflecting a year-over-year increase of 16.98%.
Earnings History
Price & Consensus
Zacks News for UTHR
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services